Aortic, Cardiogenic Shock and Interventional Cardiology

Magenta Medical, Developer of World’s Smallest Heart Pump, Closes $105M Financing Round

DAIC

JULY 29, 2024

MCS is one of the fastest growing markets in interventional cardiology. FDA for two clinical indications: high-risk percutaneous coronary intervention (HR-PCI) and cardiogenic shock (CS). The pump is delivered into the heart fully sheathed, over a guidewire, through the aorta, and across the aortic valve.

Cardiogenic Shock

Cardiogenic Shock Blood Pressure Technology Aortic valve

Critical Left Main

EMS 12-Lead

JULY 24, 2023

Category 2 : An increase in myocardial oxygen demand due to tachycardia, elevated ventricular afterload (BP or aortic stenosis), or increased wall stretch (admittedly this latter is more complicated) or a decrease in oxygen supply due to hypotension, anemia, hypoxia, or a combination of all of the above. Aortic Stenosis f.

Angina

Angina Ischemia Coronary Angiogram Stenosis

Cardiovascular Update

Magenta Medical, Developer of World’s Smallest Heart Pump, Closes $105M Financing Round

Critical Left Main

Webinars

Stay Connected